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Abstract
Eps15 Homology Domain-containing 3 (EHD3), a member of the EHD protein family that regulates endocytic recycling, is
the first protein reported to be specifically expressed in the glomerular endothelium in the kidney; therefore we generated
Ehd3
–/– mice and assessed renal development and pathology. Ehd3
–/– animals showed no overt defects, and exhibited no
proteinuria or glomerular pathology. However, as the expression of EHD4, a related family member, was elevated in the
glomerular endothelium of Ehd3
–/– mice and suggested functional compensation, we generated and analyzed Ehd3
–/–;
Ehd4
–/– mice. These mice were smaller, possessed smaller and paler kidneys, were proteinuric and died between 3–24 weeks
of age. Detailed analyses of Ehd3
–/–; Ehd4
–/– kidneys demonstrated thrombotic microangiopathy (TMA)-like glomerular
lesions including thickening and duplication of glomerular basement membrane, endothelial swelling and loss of
fenestrations. Other changes included segmental podocyte foot process effacement, mesangial interposition, and abnormal
podocytic and mesangial marker expression. The glomerular lesions observed were strikingly similar to those seen in human
pre-eclampsia and mouse models of reduced VEGF expression. As altered glomerular endothelial VEGFR2 expression and
localization and increased apoptosis was observed in the absence of EHD3 and EHD4, we propose that EHD-mediated
endocytic traffic of key surface receptors such as VEGFR2 is essential for physiological control of glomerular function.
Furthermore, Ehd3
–/–; Ehd4
–/– mice provide a unique model to elucidate mechanisms of glomerular endothelial injury which
is observed in a wide variety of human renal and extra-renal diseases.
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Introduction
Human kidneys filter about 180 liters of blood per day,
retaining most of the plasma proteins in blood and allowing
passage of water and small molecules into urine. The filtering unit
of the kidney, the glomerulus, consists of a network of capillaries
covered by specialized visceral epithelial cells, the podocytes, and
supported by the mesangial cells in the interstitium. Glomerular
capillaries are lined by very specialized glomerular endothelial cells
(GEnCs) that possess transendothelial pores or ‘‘fenestrations’’ and
an overlying negatively charged glycocalyx [1]. GEnCs and
podocytes secrete basement membranes which fuse as glomeruli
mature to form the glomerular basement membrane (GBM) [2,3].
Collectively, GEnCs, the GBM and podocytes together constitute
the glomerular filtration barrier [4–6]. Injury to or disruption of
any of its constituents compromises the integrity of the glomerular
filtration barrier resulting in proteinuria. In the recent years,
several critical molecular components of podocytes that are
indispensable for glomerular filtration have been identified. A
number of human diseases with mutated podocyte components
have also been identified and several mouse models have been
generated that have facilitated our understanding of podocyte
biology [7–14]. In comparison, our knowledge of molecular
components of GEnCs has lagged behind. This is largely due to
lack of information on functionally-critical glomerular endotheli-
um-restricted proteins and the unavailability of suitable mouse
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17838models that exhibit glomerular disease upon deletion of endothe-
lial-expressed genes.
Members of the EHD protein family (EHD1-4) have emerged
as critical regulators of endocytic traffic of membrane as well as
cell surface receptors [15]. The reported glomerular endothelium-
restricted expression of EHD3 within the kidney [16,17] suggested
the possibility that EHD protein-mediated endocytic recycling
might contribute to GEnC-specific functions. This possibility was
strengthened by recent studies that have implicated EHD proteins
in regulating physiological functions in other cell types, including
adipocytes [18], cardiomyocytes [19], myocytes [20], hepatic
sinusoidal endothelial cells [21] and neuronal cells [22]. Though
EHD3 was the first protein shown to be specifically expressed in
the glomerular endothelium, to date, its potential role in this
context has not been investigated.
EHD proteins are characterized by an EH domain at the C-
terminus, a nucleotide binding P-loop near the N-terminus and a
central coiled-coiled region. The EH domain mediates protein–
protein interactions by binding to the Asn-Pro-Phe (NPF) tri-peptide
motif present in interacting proteins and facilitates membrane
binding through association with membrane phospholipids [23,24].
TheP-loop bindsandhydrolyzesATPata veryslowrateinvitro[25],
while the coiled-coiled region participates in oligomerization [26].
To investigate the in vivo functional roles of EHD proteins we
have previously employed a gene knockout approach and such
studies of Ehd1 and Ehd4 have demonstrated their roles in normal
murine development and physiology [27–28]. Deletion of Ehd1
resulted in small testis with male infertility (27), while Ehd4 deletion
resulted in small testis with moderate reduction in sperm count (28),
indicating a role for EHD1 and EHD4 in male germ cell
development/differentiation. Deletion of Ehd1 also leads to
embryonic lethality and ocular defects whose severity varies with
the genetic background of the mouse strains used (Rainey MA et al.,
manuscript in preparation). Here, we extended this gene knockout
approach to Ehd3; however, Ehd3
–/– mice showed no discernable
pathology. Upregulation of the expression of EHD4, a related
family member, in Ehd3
–/– GEnCs led us to hypothesize that EHD4
functionally compensates for loss of EHD3. We generated Ehd3
–/–;
Ehd4
–/– mice to test this hypothesis and observed severe glomerular
disease in these mice, demonstrating a critical role for EHD3 and
EHD4 in glomerular health. This is the first report of a knockout
mouse model where deletion of genes with GEnC-enriched
expression results in phenotypes similar to human diseases with
glomerular endothelial injury as the initiating event.
Results
Generation and characterization of Ehd3
–/– mice
A recombineering strategy similar to that successfully used to
generate Ehd1 and Ehd4 null mice in our earlier studies [27,28], was
employed to target the 59untranslated region and the first exon of
Ehd3 such that targeted animals would not express EHD3 (Text S1
and Figure S1A). Genotyping by PCR (Figure S1B) and Western
blotting of organ lysates (Figure S1C) from wild-type (Ehd3
+/+),
heterozygote (Ehd3
+/–) and homozygous deleted (Ehd3
–/–) mice
confirmed successful targeting. Ehd3
–/– mice were born at expected
Mendelian ratios, were healthy and fertile with body weights
comparable to their wild-type littermates (Figure S1D & S1E).
Developmental regulation of EHD3 expression in renal
glomerular endothelium
As lack of a renal phenotype in Ehd3
–/– mice was unexpected,
we first confirmed that EHD3 is indeed expressed in the wild-type
kidney using Ehd3
–/– kidney as a negative control. Consistent with
a previous report [16], our analysis of adult Ehd3
+/+ mouse kidney
sections confirmed predominant EHD3 expression (Figure 1A) in
GEnCs as confirmed by co-staining of these cells with endothelial
markers tomato lectin (from Lycopersicon esculentum) (Figure 1C) and
CD31 (data not shown); tomato lectin recognizes N-acetyl
glucosamine (GlcNAc) and poly-N-acetyllactosamine on the
glomerular endothelium [29]. EHD3 staining was not seen in
podocytes which stained strongly with the podocyte protein
nephrin, (Figure 1E); nephrin stained podocytes form a discrete
rim surrounding EHD3-positive cells, further confirming EHD3
expression in GEnCs. The absence of staining in Ehd3
–/–
glomeruli validated the specificity of GEnC-specific EHD3
expression (Figure 1B, D and F).
We next assessed if EHD3 expression in GEnCs is develop-
mentally regulated. Nephrogenesis in mice begins by embryonic
day 11 [3] and glomerular development proceeds through a series
of nephric structures morphologically seen as vesicle, comma- and
S-shaped, developing capillary loop, and maturing glomerulus
stages. Newborn mice show a sub-cortical ‘‘nephrogenic zone’’
with easily discernable vesicular, comma and S-shaped nephric
structures and an expanding cortex with capillary loop and
maturing glomerular stages [30]. Analyses of Ehd3
+/+ kidneys at
postnatal day 2 showed EHD3 expression in the capillary loop
stage and mature glomeruli (Figure 1G and H) but not in the
earlier nephric stages, indicating that its expression is indeed
developmentally regulated.
In view of the endothelium-restricted and developmentally-
regulated expression of EHD3 in the kidney, we undertook
detailed analyses of Ehd3
–/– kidneys to characterize potentially
subtle glomerular pathology. However, no detectable glomerular
abnormalities were observed in H&E and Periodic Acid Schiff
(PAS) stained Ehd3
–/– kidney sections (Figure S2A–D). Immuno-
fluorescence microscopy showed similar patterns of staining of
endothelial, mesangial and podocyte markers in both Ehd3
+/+ and
Ehd3
–/– glomeruli (Figure S2F–M) and transmission electron
microscopic (TEM) analysis of Ehd3
–/– kidneys from 8-month old
mice showed glomerular endothelial cells with normal fenestra-
tions and intact podocyte foot processes (Figure S2N–O). Finally,
no proteinuria was detected in urine samples from Ehd3
–/– mice
on SDS-PAGE (Figure S2E) indicating that the functional integrity
of the GBM was unaffected in Ehd3
–/– kidneys.
Compensatory increase in EHD4 expression in Ehd3
–/–
glomerular endothelium
Complete absence of glomerular pathology in Ehd3
–/– kidneys
despite GEnC-enriched EHD3 expression could reflect a lack of
requirement of EHD3 in glomerular development and function, or
compensatory upregulation of other EHD proteins in the Ehd3
–/–
GEnCs. As no information is available on the relative expression
of other EHD proteins in the kidney, we undertook immuno-
staining analyses to assess if other EHD family members are also
expressed in the glomerular endothelium. Immunostaining for
EHD1, EHD2 and EHD4 showed relatively low signals in the
glomerular endothelium but markedly more prominent staining in
spatially distinct regions of the kidney: EHD1 was expressed in the
brush-border epithelium of proximal tubules (white arrows in
Figure 2A); EHD2 in the endothelium and smooth muscle cells of
interlobular arteries (white arrows, Figure 2B) and afferent
arterioles (white arrow heads in Figure 2B); and EHD4 in the
peritubular capillary endothelium (white arrows in panel
Figure 2C). Ehd1
–/– and Ehd4
–/– kidney sections were used as
controls for EHD1 and EHD4 staining, respectively (data not
shown); staining without a primary antibody was used as a control
for EHD2 staining. Thus, as EHD3 appears to be the
Renal TMA in Ehd3;Ehd4 Double Null Mice
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of glomerular defects in Ehd3
–/– mice is due to basal co-expression
of other EHD family members.
As previous studies have shown compensatory changes in EHD
protein expression upon knockout of individual family members
[27–28,31] we examined Ehd3
–/– kidneys for upregulation of other
EHD protein expression. Immunofluorescence analyses showed
lack of appreciable differences in EHD1 or EHD2 expression
between Ehd3
+/+ and Ehd3
–/– kidney sections (Figure 3A–B and
3C–D). Notably, while EHD4 expression in the peritubular
capillaries was comparable in Ehd3
+/+ and Ehd3
–/– kidney sections,
a marked increase in EHD4 expression was observed in Ehd3
–/–
Figure 1. EHD3 expression in the glomerular endothelium. (A–B) Three mm thick kidney sections from three month old male Ehd3
+/+ and
Ehd3
–/– mice were stained using antibodies to EHD3 and confocal images acquired as described. EHD3 staining (red) and DAPI staining of nuclei
(blue) are shown. White circles demarcate glomeruli. (C–D) Triple staining of kidney sections with labeled tomato lectin (green) and EHD3 (red) and
DAPI (blue) shows colocalization between EHD3 and tomato lectin staining (yellow in panel C). (E–F) Triple staining with the podocyte marker,
nephrin (green), EHD3 (red) and DAPI (blue) shows nephrin staining around endothelial EHD3 staining in panel E. EHD3 staining is absent in Ehd3
–/–
kidney sections as expected in panels B, D and F. (G–H) Kidney sections from 2 day old Ehd3
+/+ mice were double stained with EHD3 (red) and lectin
(green), yellow in panel H shows colocalization. The white line demarcates the kidney capsule in panel G and white arrows point to EHD3 expression
in capillary loop stage glomeruli. S-shaped and comma shaped glomeruli that lack EHD3 staining are clearly visible in the nephrogenic zone in panel
H. Scale bar=10 mm.
doi:10.1371/journal.pone.0017838.g001
Figure 2. Spatially distinct expression of EHD proteins in the kidney. (A–C) Kidney sections from three month old male Ehd3
+/+ and Ehd3
–/–
mice were processed and stained using antibodies to indicated EHD proteins and confocal images acquired as described in Materials and Methods.
EHD staining is shown in green. Scale bar=10 mm. White arrows point to EHD1 expression in brush border epithelium (panel A), EHD2 expression in
the interlobular arteries (panel B), and EHD4 expression in the peritubular capillaries (panel C); the white arrow head points to EHD2 expression in
afferent arterioles (panel B).
doi:10.1371/journal.pone.0017838.g002
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showed that EHD4 was specifically upregulated in the Ehd3
–/–
GEnCs (Figure 3G–J). The selective upregulation of EHD4 in
Ehd3
–/– GEnCs suggested that EHD4 might functionally compen-
sate for Ehd3 deletion and account for lack of glomerular pathology.
Combined deletion of Ehd3 and Ehd4 in mice leads to
renal pathology with proteinuria
To test the hypothesis that a compensatory increase in EHD4
expression prevents the appearance of glomerular pathology in
Ehd3
–/–mice, we intercrossed Ehd3
–/– mice with the previously
described Ehd4
–/– mice[28,31] to generate Ehd3
–/–; Ehd4
–/– double-
null mice. Ehd3
–/–;E h d 4
–/– mice were smaller (Figure 4A), displayed
markedly pale (Figure 4B) and smaller kidneys (Figure 4C),
developed severe proteinuria (Figure 4D) and died between 3–24
weeks of age. As expected, both EHD3 and EHD4 staining was
absent in Ehd3
–/–;E h d 4
–/– kidneys (Figure 4E–H). Interestingly,
EHD2 expression was upregulated in the glomerular and peritubu-
lar capillary endothelium of Ehd3
–/–; Ehd4
–/– kidneys (Figure 4K–L).
Ehd3
–/–;E h d 4
–/– mice did not show an upregulation of EHD1 in the
glomerular or peritubular capillary endothelium (Figure 4I–J), but
showed increased EHD1 expression at the proximal tubule brush
border epithelium. Overall, these results indicate that concurrent
deletion of Ehd3 and Ehd4 leads to renal pathology.
Ehd3
–/–; Ehd4
–/– mice develop thrombotic
microangiopathy
H&E and PAS staining of kidney sections from Ehd3
–/–; Ehd4
–/–
mice showed lesions characteristic of thrombotic microangiopathy
(TMA). TMA is a lesion observed in a number of human diseases
including pre-eclampsia, hemolytic uremic syndrome and malig-
nant hypertension and is defined by the primary locus of injury in
the endothelium [32]. Although the majority of human cases of
TMA exhibit variable numbers of thrombi, a percentage of cases
do not. For example, pre-eclampsia, which has the characteristic
lesions of TMA, rarely exhibits thrombi. A diagnosis of TMA is
based on a set of characteristic morphologic findings irrespective of
the presence of glomerular or arteriolar thrombi. These lesions
include endothelial cell swelling, expansion of the subendothelial
zone, duplication of the GBM, mesangial cell interposition and
evidence of red cell destruction. PAS stained Ehd3
–/–; Ehd4
–/–
mouse kidney sections showed characteristic glomerulomegaly,
thickening and duplication of the GBM, expanded and lytic-
appearing mesangium, variable degrees of mesangial interposition
and abnormal capillary loops (Figure 5A–B). Other changes
included tubular dilation and protein reabsorption droplets in
proximal tubules. The glomerular changes were more easily visible
with the Jones Methenamine silver stain (Figure 5C–D). Notably,
we did not observe any thrombi in the Ehd3
–/–; Ehd4
–/– mouse
kidney sections analyzed despite other hallmarks of TMA.
In order to assess the ultrastructural alterations in glomerular
endothelial cells of Ehd3
–/–;E h d 4
–/– mice, we performed TEM of
kidney sections. Endothelial cells with a normal pattern of
fenestrations (black arrow heads, Figure 6A and Ai), podocytes
with intact foot processes (white arrows, Figure 6A and Ai) and
normal GBM were identified in Ehd3
+/–;E h d 4
+/– kidneys
(Figure 6A and Ai) and in kidney sections from Ehd3
–/–;
Ehd4
+/– and Ehd3
+/–; Ehd4
–/– mice (data not shown), indicating
that the presence of at least one copy of Ehd3 or Ehd4 gene
Figure 3. Compensatory increase in EHD4 in the Ehd3
–/– glomerular endothelium. (A–B) Confocal images of formalin-fixed, paraffin-
embedded 3 mm thick kidney sections from 5 month old male Ehd3
+/+ and Ehd3
–/– mice were immunostained with antibodies to EHD1, (C–D) EHD2
and (E–F) EHD4. EHD protein staining is shown in green. One glomerulus in each panel is denoted by a white arrow. Scale bar=20 mm. (G–J) Sections
triple stained for EHD4 (red, panel G–J), labeled tomato lectin (green) and DAPI (blue) are shown. Yellow in panel J shows colocalization between
lectin and EHD4. White circles demarcate glomeruli. Scale bar=10 mm.
doi:10.1371/journal.pone.0017838.g003
Renal TMA in Ehd3;Ehd4 Double Null Mice
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capillaries.
In contrast, TEM of Ehd3
–/–; Ehd4
–/– kidney sections
(Figure 6B–D) revealed swollen glomerular endothelial cells
without fenestrations, podocytes with variable segmental foot
process effacement and thickening and lamellation of GBM (t,
Figure 6B, Bi and D) with widening of subendothelial zones
containing ‘‘flocculent material’’ (f, Figure 6C), lucencies within
mesangial areas suggesting lysis (m, Figure 6C) and variable
mesangial interposition (i, Figure 6C). Many glomerular endothe-
lial cells contained numerous small structures that looked like
abnormal endosomes or vacuoles (Figure 6B, Bi and Figure 6D,
black arrows). These structures were never observed in kidneys
from littermate controls. Other changes observed included
electron dense deposits in mesangial areas (data not shown),
vacuolation within the mesangium and platelet aggregation (p,
Figure 6D) within capillary lumens. It is interesting to note that
marked pathology was seen not only in endothelial cells but also in
podocytes and mesangial cells within the glomeruli. Characteristic
lesions of TMA were seen in all Ehd3
–/–; Ehd4
–/– kidneys analyzed
(at ages of day 17 (d17), d22, d23, d39, d45 and d180), while the
only 6 month old animal showed cellular infiltration and collagen
deposition as additional renal changes (data not shown). The
observed lesions were strikingly similar to that seen in human
TMAs like pre-eclampsia and in mouse models with reduction of
podocyte-expressed VEGF [32–34].
Staining and distribution of endothelial, podocytic and
mesangial markers were drastically altered in Ehd3
–/–;
Ehd4
–/– glomeruli
To further characterize the lesions observed by light microscopy
and TEM, we performed immunostaining for glomerular cell type
Figure 4. Proteinuria in Ehd3
–/–; Ehd4
–/– mice. (A) Seventeen day-old Ehd3
–/–; Ehd4
–/– and littermate Ehd3
+/–; Ehd4
+/– mice were euthanized and
photographed. (B) Kidneys dissected from mice shown in (A) were photographed, note the smaller and paler Ehd3
–/–; Ehd4
–/– kidneys. (C) Kidneys
weights from 3-week old Ehd3
–/–; Ehd4
–/– mice and littermate controls were plotted, error bars indicate standard deviation. (D) Urine samples from 17
day old mice of indicated genotypes (lane 2 & 3) and a 3 month old Ehd3
–/– mouse (lane 4) were run on a 7.5% SDS-PAGE and stained with Coomassie
Blue. Gels were scanned following de-staining. Bovine serum albumin (BSA) was used as a positive control (lanes 5 and 6). MWM, molecular weight
marker (lane 1). Lanes 1–6 were run on the same gel but were noncontiguous. (E–H) 3 mm kidney sections from mice shown in (A) were stained for
EHD3 and EHD4 (green) and confocal images acquired as described. White arrows point to expression of EHD3 and EHD4 in Ehd3
+/–; Ehd4
+/– kidney
sections (panel E and G) and absence of expression in Ehd3
–/–; Ehd4
–/– kidney sections (panel F and H). (I–L) Kidney sections from mice shown in (A)
were stained for EHD1 (green, panels I–J) and EHD2 (green, panels K–L) and confocal images acquired as described. White arrows point to expression
of EHD1 and EHD2 in kidney sections, while white arrow heads point to glomeruli. Scale bar=20 mm.
doi:10.1371/journal.pone.0017838.g004
Renal TMA in Ehd3;Ehd4 Double Null Mice
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synaptopodin were severely altered in Ehd3
–/–; Ehd4
–/– glomeruli
with loss of the lobulated staining pattern seen in control Ehd3
+/–;
Ehd4
+/– glomeruli (Figure 7A–D). Tomato lectin staining of
GEnCs and desmin staining of mesangial cells showed markedly
altered expression patterns; Ehd3
–/–; Ehd4
–/– glomeruli had fewer
lectin-positive endothelial cells (Figure 7E–F) and desmin expres-
sion was greatly upregulated in the glomeruli and interstitium
when compared to littermate controls (Figure 7G–H). These
studies indicate that concurrent deletion of Ehd3 and Ehd4
adversely affects all glomerular cell types.
Altered localization of VEGFR2 and increased apoptosis
in Ehd3
–/–; Ehd4
–/– glomeruli
Given the similarity of glomerular lesions in Ehd3
–/–; Ehd4
–/–
mice with those seen in mice with 50% reduced podocytic VEGF
expression [33,34] and in pre-eclampsia in humans [32], we
analyzed if VEGF, VEGFR1 or VEGFR2 expression was altered
in Ehd3
–/–; Ehd4
–/– glomeruli. While the expression pattern of
VEGF and VEGFR1 in Ehd3
–/–; Ehd4
–/– glomeruli were
comparable to those in Ehd3
+/–; Ehd4
+/– littermate control
glomeruli (data not shown), they displayed a dramatically altered
expression of VEGFR2 on endothelial cells, as seen upon co-
staining for VEGFR2 and tomato lectin (Figure 8A–F). Tomato
lectin staining was very diffuse and fewer GEnCs stained positive
for VEGFR2 in Ehd3
–/–; Ehd4
–/– glomeruli; in contrast, nearly all
GEnCs showed VEGFR2 staining in control Ehd3
+/–; Ehd4
+/–
glomeruli. Notably, some Ehd3
–/–; Ehd4
–/– GEnCs showed
dramatically more intense intracellular VEGFR2 staining com-
pared to control glomeruli (white arrows, Figure 8F), suggesting
potential defects in VEGFR2 trafficking.
In view of the altered expression and distribution of VEGFR2 in
Ehd3
–/–; Ehd4
–/– glomeruli and the known role of VEGF signaling
in regulating glomerular physiology [34–36], we assessed if
Ehd3
–/–; Ehd4
–/– glomeruli showed increased apoptosis. Indeed
TUNEL detected a significantly large increase in apoptotic cells in
Ehd3
–/–; Ehd4
–/– glomeruli compared to Ehd3
+/–; Ehd4
+/–
glomeruli (Figure 8G–I).
Discussion
Studies reported here describe the generation and character-
ization of a mouse model in which concurrent deletion of two
endocytic recycling regulatory proteins, EHD3 and EHD4, results
in renal thrombotic microangiopathy (TMA), a pathological lesion
commonly seen in diverse clinical conditions. TMA is also seen in
pre-eclampsia, a condition that affects about 5% of all pregnancies
and is thus the most common glomerular disease in the world [32].
Irrespective of the clinical condition, the initiating event in TMA is
thought to be an insult or injury to the endothelium. Though
research in recent years has remarkably increased our under-
standing of the cell types in the glomeruli, much is still unknown
about the glomerular endothelial cell. Whole-body deletion of
endothelial-expressed genes in mice often results in embryonic
lethality precluding analyses of endothelial cell function in the
maturing glomerulus. A limited set of genes have recently been
shown to be specifically expressed in the glomerular endothelium
[16,17], however, knockout mouse models of these genes have not
been described. The lack of suitable animal models describing
Figure 5. Ehd3
–/–; Ehd4
–/– mice develop thrombotic microangiopathy. (A–B) Kidney sections from 22 day old Ehd3
–/–; Ehd4
–/– mice and
littermate controls were stained with PAS to visualize tubular and glomerular basement membranes. Healthy capillary loops are seen in the Ehd3
+/–;
Ehd4
+/– glomeruli (panel A) while Ehd3
–/–; Ehd4
–/– kidney sections showed endothelial swelling (e), enlarged glomeruli with segmental thickening (t),
duplication of basement membranes (d) and mesangiolysis (m). Some tubular dilation is also seen (asterisks). (C–D) Jones methenamine silver (JMS)
staining of kidney sections from Ehd3
–/–; Ehd4
–/– mice (panel D) and littermate controls (panel C) show duplicated and thickened glomerular
basement membrane, expanded mesangium and relatively avascular glomeruli in Ehd3
–/–; Ehd4
–/– kidney sections. Thick black arrows point to
glomeruli.
doi:10.1371/journal.pone.0017838.g005
Renal TMA in Ehd3;Ehd4 Double Null Mice
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specifically expressed in the glomerular endothelium has ham-
pered research into this important cell type in the renal
glomerulus. Thus, our studies reporting a gene knockout mouse
model that recapitulates features of human TMA represents a
major step forward that should facilitate mechanistic and
pharmacological explorations of glomerular endothelial injury.
Since we were unable to find unaltered endothelium in the
double null mice of various ages analyzed, our results suggest that
processes regulated by EHD proteins are critical to glomerular
endothelial health. In view of the extensive changes in the
endothelial compartment, together with endothelial-specific ex-
pression of EHD3 (and increased endothelial EHD4 in Ehd3
–/–
glomeruli), it is reasonable to suggest that the changes seen in
Figure 7. Alteration in endothelial, podocytic and mesangial cells in Ehd3
–/–; Ehd4
–/– glomeruli. (A–D, G–H) Kidney sections from 39 day
old Ehd3
+/–; Ehd4
+/– and Ehd3
–/–; Ehd4
–/– mice were immunostained with antibodies to synaptopodin (A–B), nephrin (C–D) and desmin (G–H) as
described in Materials and Methods. (E–F) Endothelial cells were visualized by labeled tomato lectin staining (green) and DAPI (blue) was used to
counterstain nuclei. Markedly altered staining patterns were observed in the Ehd3
–/–; Ehd4
–/– kidney sections in each case. Scale bar=20 mm in panels
A–F and 10 mm in panels G–H. White lines demarcate glomeruli in panels G–H.
doi:10.1371/journal.pone.0017838.g007
Figure 6. Ultrastructural changes in Ehd3
–/–; Ehd4
–/– glomeruli. (A) Endothelial cells with fenestrations (black arrow heads) and podocytes with
intact foot processes (white arrows) are evident in the Ehd3
+/–; Ehd4
+/– section. (Ai) Inset shows a representative higher magnification image, inset
scale bar=500 nm. (B) Abnormally thickened and lamellated basement membranes (t), swollen endothelium without fenestrations and effacement of
podocytes foot processes were seen in the Ehd3
–/–; Ehd4
–/– kidney section. Multiple small ‘‘holes’’ presumed to be abnormal endosomes were seen in
the endothelium (black arrows); these structures are clear in the higher magnification image in B. Inset scale bar=500 nm. Scale bars=2 mm. (C–D)
Images from Ehd3
–/–; Ehd4
–/– kidneys also show additional changes including mesangiolysis (m), mesangial interposition (i), flocculent subendothelial
material (f) and platelet (p) accumulation in a capillary loop. GBM, glomerular basement membrane. Scale bars=5 mm.
doi:10.1371/journal.pone.0017838.g006
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endothelial defects caused by deletion of Ehd3 and Ehd4. This is
not unexpected as cell types within the glomerulus communicate
via soluble mediators; elegant studies have shown that injury to
any one cell type could compromise the functional integrity of
other cell types and the glomerulus as a whole [35,37–39]. For
example, soluble factors such as platelet derived growth factor
(PDGF) BB elaborated by healthy endothelial cells have been
shown to be critical to mesangial health [37] and this might
explain the mesangial changes seen in Ehd3
–/–; Ehd4
–/– mice. It is
also possible that the observed alterations in VEGFR2 expression
in glomerular endothelial cells (Figure 8) might affect their health
and secondarily contribute to the podocyte pathology seen. Future
studies to delete Ehd3 and Ehd4 in a cell type-specific manner
(endothelium or podocytes) using specific Cre-recombinase
expressing transgenic mouse lines will help unequivocally
distinguish the direct versus indirect effects of endothelial EHD3
and EHD4 loss on the podocyte. Towards this end, we have
generated double Ehd3
fl/fl; Ehd4
fl/fl mice that should allow such
experiments to be carried out in the future.
The TMA observed in Ehd3
–/–; Ehd4
–/– glomeruli bear a
striking resemblance to that seen in mouse models with reduced
podocyte VEGF expression and a recent mouse model with
inducible whole-body deletion of VEGFR2 [40]. This is especially
Figure 8. Altered VEGFR2 localization and increased apoptosis in Ehd3
–/–; Ehd4
–/– glomeruli. (A–F) Kidney sections from Ehd3
+/–; Ehd4
+/–
and Ehd3
–/–; Ehd4
–/– mice were immunostained with antibodies to VEGFR2 (red). Labeled lectin (green) was used to mark endothelial cells (B and E),
while DAPI (blue) stained nuclei (A and D). Uniform low level of VEGFR2 staining in seen in lectin positive glomerular endothelial cells in the Ehd3
+/–;
Ehd4
+/– glomeruli (panel C), while diffuse and abnormal lectin staining was seen in the Ehd3
–/–; Ehd4
–/– glomeruli (panel F), few lectin positive cells
showed intense VEGFR2 staining (white arrows, panel F). (G–I) Kidney sections from Ehd3
+/–; Ehd4
+/– and Ehd3
–/–; Ehd4
–/– mice were subjected to
TUNEL assay as described in Materials and Methods. Confocal images of TUNEL staining (green) are shown (panels G–H), white arrow points to
apoptotic nuclei (panel H). About 45 glomeruli each were counted in 12 kidney sections to arrive at the graph (panel I). Error bars indicate standard
deviation (**indicates P,0.05 using two-tailed analysis).
doi:10.1371/journal.pone.0017838.g008
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altering the levels of VEGF or its receptors, VEGFR1 and
VEGFR2 expressed in the glomerular endothelium. The marked
alterations in VEGFR2 expression in glomerular endothelial cells
and the increased apoptosis seen in Ehd3
–/–; Ehd4
–/–glomeruli,
however point to a possible role for EHD proteins in the endocytic
traffic of VEGFR2 and subsequent regulation of VEGF mediated
signaling in the glomeruli. It has been demonstrated that at steady
state VEGFR2 localizes to the cell surface and intracellular vesicles
presumed to be sorting endosomes [41]. In response to VEGF
addition, recycling of intracellular VEGFR2 to the cell surface
increases to allow higher VEGF binding and signaling [41,42].
Since EHD3 [26] and EHD4 [43] are both known to regulate
trafficking out of sorting endosomes, and in view of the appearance
of abnormal vesicular structures in endothelial cells as seen by
TEM, it is possible that altered recycling of VEGFR2 out of
sorting endosomes in Ehd3
–/–; Ehd4
–/– glomerular endothelial cells
might impair VEGF signaling resulting in the phenotypes we
observe. It is noteworthy that no differences in VEGFR1 staining
were noticed between Ehd3
–/–; Ehd4
–/– and control glomeruli.
This is not surprising as VEGFR1 trafficking has not been shown
to be regulated by endocytic regulators in the early or recycling
pathway; hence we would not expect Ehd3 and Ehd4 deletion to
affect trafficking of VEGFR1.
While we have not yet found a relevant endothelial cell system
to analyze whether VEGFR2 distribution and expression pattern
in Ehd3
–/–; Ehd4
–/– mice might reflect its altered endocytic traffic,
studies of individual siRNA-mediated knock-down of EHD3 [26]
or EHD4 [43] in HeLa cells indicate that they control traffic of
transferrin receptor out of sorting endosomes to a recycling
compartment and double knock-down of EHD3 and EHD4 has
an identical effect (data not shown). As VEGFR2 has been shown
to reside in a sorting endosomal compartment and to recycle to the
cell surface upon VEGF stimulation [41,42], absence of EHD3
and EHD4 in glomerular endothelial cells might be expected to
impose a block to its recycling and thus disrupt its signaling.
Given the roles of EHD proteins in regulating endocytic
recycling, it is likely that loss of EHD3 and EHD4 causes aberrant
trafficking of key receptors such as VEGFR2, that are critical for
maintenance of glomerular endothelial cell function and endothe-
lial-cell dependent inter-cellular signaling critical for glomerular
health. Thus, further studies using the experimental model
described here should help link the basic cell biological processes
of endocytic traffic, sorting and recycling of such receptors to the
pathogenesis of endothelial injury which is an integral part of a
number diseases of substantial human health importance.
Materials and Methods
Breeding and maintenance of mice colonies
Male and female Ehd3
+/– mice were crossed to generate Ehd3
+/+,
Ehd3
+/– and Ehd3
–/– mice. To generate Ehd3
–/–; Ehd4
–/– mice, the
previously described Ehd4
–/– mice [28] were mated to Ehd3
–/– mice
to generate Ehd3
+/–; Ehd4
+/– mice and these were intercrossed to
give rise to Ehd3
–/–; Ehd4
–/– mice. Animals were genotyped by
tail PCR and ink-tattooed on toes for identification. Primer
sequences for PCR genotyping are available on request. All
experiments involving animals were approved by the University of
Nebraska Medical Center Institutional Animal Care and Use
Committee and carried out under the approved IACUC protocol
number 07-061-FC12. All animals were treated humanely in
accordance with institutional guidelines and that of the National
Institutes of Health (NIH) Guide for the Care and Use of
Laboratory Animals.
Tissue staining
Formalin fixed, paraffin embedded, 3 mm kidney sections from
mice of the indicated genotype and ages were processed as
described previously [28] and H&E, PAS and JMS staining was
performed using standard procedures by the Tissue sciences and
Pathology and Microbiology core facilities. Immunostaining was
performed as described previously [28]. The following antibodies
were purchased commercially and used: CD31 (1:50), WT-1
(1:50), nephrin (1:50), synaptopodin (1:50), desmin (1:50) and
VEGFR2 (1:50). Fluorescein labeled tomato lectin (from L.escu-
lentum) was commercially purchased (Vector labs, FL-1171). For
EHD protein staining, formalin fixed, 3 mm kidney sections were
deparaffinized and immunostained as described previously.
Polyclonal rabbit anti-EHD3 primary antibody was used at a
1:200 dilution, while polyclonal rabbit anti-EHD1, EHD2 and
EHD4 primary antibodies were used at a 1:50 dilution in PBS/5%
fetal bovine serum and a goat anti-rabbit Alexa Fluor 488 (or 594,
Invitrogen) secondary antibody was used at 1:200 dilution in PBS.
The slides were mounted in Vectashield (Vector Labs) containing
DAPI. Confocal images were acquired with a LSM510 fluores-
cence confocal microscope (Carl Zeiss, Thornwood, NY).
Analyses of proteinuria
Urine from mice of indicated genotypes was assayed for
proteinuria using a dip-stick method with Albustix (Siemens).
Urine samples were boiled for 5 minutes in equal volumes of 2X
sample buffer and 0.8 to 2 ml was loaded on a 7.5% SDS-PAGE
gel. Bovine serum albumin (BSA) was used as a positive control.
Following separation of proteins, the gel was stained using
Coomassie Brilliant Blue and images were scanned following de-
staining in water.
Electron Microscopy
Kidneys were fixed in a 2.0% paraformaldehyde/2.5%
glutaraldehyde phosphate buffered fixative, secondarily fixed with
1% osmium tetroxide, dehydrated using a graded acetone series
and infiltrated using Polybed 812 epoxy resin. Blocks were
polymerized at 60uC. Sections were thinned at 70 nm and stained
using uranyl acetate and lead stains followed by scanning under a
JEOL 1230 transmission electron microscope. Digital images were
taken using a KeenView high-resolution camera and Soft Imaging
Solutions AnalySIS ITEM digital software.
TUNEL
For TUNEL assay, 3 mm neutral buffered formalin fixed kidney
sections from d17, d23 and d45 Ehd3
–/–; Ehd4
–/– mice and
littermate controls were deparaffinized and following antigen
retrieval, an In Situ Cell Death Detection kit, POD (Roche) was
used for TUNEL assay which was performed following the
manufacturer’s instructions. Appropriate negative and positive
controls were included in each experiment. Confocal images of
TUNEL were acquired with a LSM510 fluorescence confocal
microscope (Carl Zeiss, Thornwood, NY) under either a 63X
objective. TUNEL positive cells were counted from 12 sections (1
section/kidney, 2 kidneys/mice, 3 mice/genotype) and plotted.
Supporting Information
Figure S1 Generation and characterization of Ehd3
–/–
mice. (A) Partial restriction map of the murine Ehd3 locus, the
targeting vector and the mutated Ehd3 loci is depicted. LoxP
sequences were inserted to flank the first exon such that it could be
deleted by Cre/loxP-mediated recombination. Black rectangles
represent exons; black and grey triangles represent loxP and FRT
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PLoS ONE | www.plosone.org 9 March 2011 | Volume 6 | Issue 3 | e17838sequences, respectively. RI, EcoRI; H, HindIII. (B) Samples of tail
DNA from 10 day old mice were genotyped by PCR. Three
primers were used in a single duplex PCR reaction to amplify the
WT Ehd3 allele (377 bp) and the deleted allele (488 bp), and the
products were separated by agarose gel electrophoresis to
determine one of three genotypes of mice carrying various Ehd3
alleles. (C) Western blotting of organ lysates from Ehd3 mice. Fifty
mg aliquots of organ lysates from three month-old Ehd3 wild-type
(Ehd3
+/+), heterozygote (Ehd3
+/–) and null (Ehd3
–/–) male mice
were subjected to Western blotting with antisera raised against
human EHD proteins as described under Materials and Methods.
The membrane was serially probed beginning with EHD3,
followed by EHD1 and EHD4 and then EHD2 antibodies. The
* denotes bleed-through from the previous blot. In the kidney and
brain lysates, the anti-EHD3 antibody recognizes smaller sized
products that may represent tissue-specific alternate spliced
products of EHD3 lacking the first exon or they may be non-
specific bands detected by the antibody. MWM, Molecular weight
marker. (D and E) Quantitative growth curves of female (D) and
male (E) littermate Ehd3 mice (numbers in parentheses indicate
number of mice of each genotype weighed).
(TIF)
Figure S2 Lack of glomerular phenotypes in Ehd3
–/–
mice. (A–D) Formalin-fixed, paraffin- embedded, three mm thick
kidney sections from 3–5 month old male Ehd3
+/+ and Ehd3
–/–
mice were stained with H&E and PAS. (F–M) Immunostaining
was performed on kidney sections using antibodies to synaptopo-
din (F–G), nephrin (H–I), WT-1(J–K) and desmin (L–M) as
described in Materials and Methods. Scale bar=10 mm. (E) Two
ml of boiled urine samples from 8 month old mice of indicated
genotypes were run on a 7.5% SDS-PAGE and stained using
Coomassie Blue. Gels were scanned following de-staining. Bovine
serum albumin (BSA) was used as a positive control (lanes 2 and 3).
MWM = molecular weight marker (lane 1).Lanes 1–6 were run on
the same gel but were noncontiguous. (N–O) Electron micrographs
of glomeruli from 8 month old Ehd3
+/+ and Ehd3
–/– mice are
shown. Endothelium with fenestrations (black arrows) and podo-
cytes with intact foot processes are seen in Ehd3
+/+ and Ehd3
–/–
mice. Scale bar=2 mm.
(TIF)
Text S1 Supporting Information Materials and Methods
(DOC)
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